Key Record Dates
| ClinicalTrials.gov Identifier: | NCT01375842 |
|---|---|
| Brief Title: | A Study of Atezolizumab (an Engineered Anti-Programmed Death-Ligand 1 [PDL1] Antibody) to Evaluate Safety, Tolerability and Pharmacokinetics in Participants With Locally Advanced or Metastatic Solid Tumors |
| First Submitted : | June 16, 2011 |
| First Submitted that Met QC Criteria : | June 16, 2011 |
| First Posted : | June 17, 2011 (Estimate) |
| Last Update Submitted that Met QC Criteria : | December 10, 2018 |
| Last Update Posted : | December 11, 2018 |